JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:1576-1583
© 2009 International Anesthesia Research Society
doi: 10.1213/ane.0b013e3181af40e0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ane.0b013e3181af40e0v1
109/5/1576    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Cunha-Goncalves, D.
Right arrow Articles by Blomquist, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunha-Goncalves, D.
Right arrow Articles by Blomquist, S.
Related Collections
Right arrow Cardiovascular
Right arrow Critical Care
Right arrow Mechanisms
Right arrow Resuscitation
Right arrow Pharmacology


CRITICAL CARE AND TRAUMA

Inotropic Support During Experimental Endotoxemic Shock: Part II. A Comparison of Levosimendan with Dobutamine

Doris Cunha-Goncalves, MD*, Valeria Perez-de-Sa, MD, PhD{dagger}, Anders Larsson, MD, PhD{ddagger}, Johan Thörne, MD, PhD§, and Sten Blomquist, MD, PhD*

From the *Departments of Cardiothoracic Anesthesia and Intensive Care, and {dagger}Pediatric Anesthesia and Intensive Care, Lund University Hospital, Sweden; {ddagger}Department of Anesthesia and Critical Care, Uppsala University Hospital, Sweden; and §Department of Surgery, Helsingborg Hospital, Sweden.

Address correspondence to Doris Cunha Goncalves, MD, Heart and Lung Division, Department of Cardiothoracic Surgery, Anesthesia and Intensive Care, Lund University Hospital, SE-221 85 Lund, Sweden. Address e-mail to doris.cunha_goncalves{at}med.lu.se.

BACKGROUND: We compared the association of levosimendan or dobutamine with norepinephrine for the maintenance of systemic and hepatosplanchnic perfusion during early endotoxemic shock.

METHODS: Twenty anesthetized pigs (26.8 ± 0.5 kg) were instrumented with flow probes and catheters to monitor systemic and regional perfusion as described in our companion article in this issue of the journal. Two animals were excluded because of surgical complications. Oxygen consumption (VO2) was measured by indirect calorimetry. Starting 1 h after instrumentation, an endotoxin infusion (Escherichia coli lipopolysaccharide, 2 µg · kg–1 · h–1) was administered for 300 min. Sixty minutes after the start of endotoxin, the animals were fluid resuscitated (20 mL/kg dextran 70); at 120 min, they were randomized into three groups of six animals each: levosimendan (25–50 µg · kg–1 · h–1), dobutamine (10–20 µg · kg–1 · min–1), and control. In the first two groups, norepinephrine (0.5–2 µg · kg–1 · min–1) was added when mean arterial blood pressure (MAP) ≤ 65 mm Hg. Crystalloids were given to maintain filling pressures ≥ baseline. The data were divided into two subsets: before (0–120 min, all animals) and after (120–300 min, three groups) randomization, and analyzed by analysis of variance. P < 0.05 was considered significant.

RESULTS: At 120 min, cardiac output was 15% higher (P < 0.001), systemic vascular resistance was 30% lower (P < 0.001), and MAP decreased 12.5% (P = 0.004); blood flow in the hepatic artery, superior mesenteric artery, and portal vein had increased by 100% (P = 0.004), 60% (P < 0.001), and 20% (P < 0.001), respectively. Between 120 and 300 min, cardiac output and systemic oxygen delivery decreased 50% in control animals (P < 0.05), remained unchanged in the levosimendan group, and increased 60% with dobutamine (P = 0.05). MAP (P = 0.043) and VO2 (P = 0.001) decreased 20% in the control group. Portal vein flow decreased in the control (50%) and levosimendan (30%) groups (P < 0.001) and was therefore higher in the dobutamine group (P = 0.003) at 300 min. Hepatic and gut oxygen deliveries decreased in the levosimendan (50%, and 30%, respectively, P < 0.001) and control groups (70% and 45%, respectively, P < 0.05); thus, regional oxygen deliveries were greater in the dobutamine group (P < 0.05). In this group, mixed venous and hepatic vein oxygen saturation were maintained; the latter variable was higher than in the other groups (P < 0.05). Although unchanged with dobutamine, arterial (P = 0.020), portal (P = 0.020), and hepatic vein (P = 0.034) lactate concentrations increased twofold with levosimendan.

CONCLUSION: In volume-resuscitated endotoxemic pigs, the association of either levosimendan or dobutamine with norepinephrine preserved systemic blood flow, oxygen delivery, and VO2. However, only dobutamine-norepinephrine maintained portal blood flow, which was associated with preservation of splanchnic and hepatic oxygen homeostasis and stable lactate concentrations.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
D. De Backer and H. Bracht
Levosimendan in Early Sepsis: When Good Ideas Give Poor Results
Anesth. Analg., November 1, 2009; 109(5): 1367 - 1369.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.